Abstract
Long-term follow-up studies in Charcot–Marie-Tooth disease type 1 duplication (CMT1A) are scanty. Here we describe a longitudinal study in a CMT1A pedigree. Our CMT1A pedigree comprised 11 examined patients, ages between 13 and 83 (median, 36) years, serially evaluated for up to 26 years. In all 11 patients we carried out electrophysiological evaluation, and in three of them magnetic resonance imaging (MRI) of lower-limb musculature. The 54-year-old proband patient, yearly examined as of age 28, developed at age 48 gradual and progressive distal lower-leg weakness ascending to thigh musculature. His serial electrophysiological studies showed diffuse slowing of motor conduction velocity, absence or severe attenuation of distal compound muscle action potentials, and spontaneous muscle activity in the tibialis anterior and rectus femoris. Two MRI studies of lower limbs, at ages 51 and 54, showed extensive fatty atrophy of lower-leg musculature, and progressive and distally accentuated fatty atrophy of anterior and posterior femoral muscles. An outstanding finding in the first MRI was the presence of marked edema of anterior femoral musculature, which to a great degree was replaced by fatty atrophy in the second study. Muscle edema was also noted in lower-leg and posterior femoral musculature. There was minimal fatty atrophy of the gluteus maximus, the remaining pelvic muscles being preserved. The other ten patients showed mild or moderate phenotype, which remained quiescent over the period of observation. Electrophysiological studies disclosed diffuse and uniform slowing of nerve conduction velocities; in no case was spontaneous muscle activity recorded. MRI showed the CMT1A characteristic pattern of distally accentuated fatty atrophy involving foot and lower-leg musculature with preservation of thigh musculature. We conclude that a small proportion of patients with CMT1A develop a late progression of disease manifested with accentuated distal leg weakness ascending to involve thigh musculature, and that long-term follow-up is essential for its detection.
Similar content being viewed by others
References
Berciano J, Combarros O, Calleja J, Polo JM, Leno C (1989) The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve 12:302–306
Berciano J, García A, Calleja J, Combarros O (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie-Tooth disease 1A duplication. Neuromuscul Disord 10:419–424
Berciano J, García A, Combarros O (2003) Initial semeiology in children with Charcot–Marie-Tooth disease. Muscle Nerve 27:34–39
Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176
Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot–Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823
Buchthal F (1957) An introduction to electromyography. Scandinavian University Books, Copenhagen
Burns J, Ryan MM, Ouvrier RA (2009) Evolution of foot and ankle manifestations in children with CMT1A. Muscle Nerve 39:58–66
Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Moon H, Park KD, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie-Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618
Dyck PJ, Lambert EH (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 39:1032–1038
Dyck PJ, Karnes JL, Lambert EH (1989) Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 39:1302–1308
Farber JM, Buckwalter KA (2002) MR imaging in nonneoplastic muscle disorders of the lower extremity. Radiol Clin North Am 40:1013–1031
Fleckenstein JL, Watumull D, Conner KE, Ezaki M, Greenlee RG Jr, Bryan WW, Chason DP, Parkey RW, Peshock RM, Purdy PD (1993) Denervated human skeletal muscle: MR imaging evaluation. Radiology 187:213–218
Gabreëls-Festen AA, Joosten EM, Gabreëls FJ, Jennekens FG, Janssen-van Kempen TW (1992) Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN) type 1. J Neurol Sci 107:45–54
Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437
García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie-Tooth disease type 1A with 17p duplication in early infancy and childhood, a longitudinal clinical and electrophysiological study. Neurology 50:1061–1067
Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202
Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC (1994) Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res 304:78–83
Hallam PJ, Harding AE, Berciano J, Barker DF, Malcolm S (1992) Duplication of part of chromosome 17 is commonly associated with hereditary motor and sensory neuropathy type I (Charcot–Marie-Tooth disease type I). Ann Neurol 31:570–572
Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280
Hoogendijk J, de Visser M, Bolhuis PA, Hart AAM, Ongerboer de Visser BM (1994) Hereditary motor and sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 17:85–90
Kendall HO, Kendall FP, Wadsworth GE (1974) Músculos: pruebas y funciones. JIMS, Barcelona
Kohl B, Fischer S, Groh J, Wessig C, Martini R (2010) MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot–Marie-Tooth 1A neuropathy. Am J Pathol 176:1390–1399
Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neuronal dysfunction and axonal degeneration in Charcot–Marie-Tooth disease type 1A. Brain 123:1516–1527
Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot–Marie-Tooth disease type 1A. Cell 66:219–232
May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ (2000) Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 20:S295–S313
Mendell JR, Kissel JT, Cornblath DR (eds) (2001) Diagnosis and management of peripheral nerve disorders. Oxford University Press, Oxford
Nicholson GA (1991) Penetrance of the hereditary motor and sensory neuropathy Ia mutation: assessment by nerve conduction studies. Neurology 41:547–552
Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA (1991) Duplication in chromosome 17p11.2 in Charcot–Marie-Tooth neuropathy type Ia (CMT Ia). Neuromuscul Disord 1:93–97
Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214
Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP (2008) Neuropathy progression in Charcot–Marie-Tooth disease type 1A. Neurology 70:378–383
Verhamme C, van Schaik IN, Koelman JHTM, de Haan RJ, Vermeulen M, de Visser M (2004) Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol 251:1491–1497
Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M (2009) The natural history of Charcot–Marie-Tooth type 1A in adults: a 5-year follow-up study. Brain 132:3252–3262
Yiu EM, Burns J, Ryan MM, Ouvrier RA (2008) Neurophysiologic abnormalities in children with Charcot–Marie-Tooth disease type 1A. J Peripher Nerv Syst 13:236–241
Acknowledgments
We deeply thank our patients for their collaboration in this study, Mar Ruiz, Rosario Repoila and Marta de la Fuente for technical support, and John Hawkins for stylistic revision. Written consent to publish was obtained. This study was supported by CIBERNED and FIS Grant PI07/132E.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berciano, J., Gallardo, E., García, A. et al. Clinical progression in Charcot–Marie-Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family. J Neurol 257, 1633–1641 (2010). https://doi.org/10.1007/s00415-010-5580-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-010-5580-x